High Vista Strategies LLC Apellis Pharmaceuticals, Inc. Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 108,714 shares of APLS stock, worth $2.62 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
108,714
Previous 35,975
202.19%
Holding current value
$2.62 Million
Previous $1.04 Million
234.52%
% of portfolio
1.43%
Previous 0.41%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$295 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$287 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$285 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$243 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$232 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.65B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...